8 Patents
- US123110102025Formulated And/or Co-formulated Liposome Compositions Containing Toll-like Receptor(“tlr”) Agonist Prodrugs Useful in the Treatment of Cancer and Methods Thereof
Nammi Therapeutics, Inc.
0 cites - US122864032025Formulated And/or Co-formulated Liposome Compositions Containing IDO Antagonist Prodrugs Useful in the Treatment of Cancer and Methods Thereof
Nammi Therapeutics, Inc.
0 cites - US120594702024Formulated And/or Co-formulated Liposome Compositions Containing PD-1 Antagonist Prodrugs Useful in the Treatment of Cancer and Methods Thereof
Nammi Therapeutics, Inc.
0 cites - US118966462024Formulated And/or Co-formulated Liposome Compositions Containing Toll-like Receptor (“TLR”) Agonist Prodrugs Useful in the Treatment of Cancer and Methods Thereof
Nammi Therapeutics, Inc.
0 cites - US118332092023Formulated And/or Co-formulated Liposome Compositions Containing PD-1 Antagonist Prodrugs Useful in the Treatment of Cancer and Methods Thereof
Nammi Therapeutics, Inc.
0 cites - US118013042023Formulated And/or Co-formulated Liposome Compositions Containing TFGB Antagonist Prodrugs Useful in the Treatment of Cancer and Methods Thereof
Nammi Therapeutics, Inc.
0 cites - US117448742023Formulated And/or Co-formulated Liposome Compositions Containing Toll-like Receptor (“TLR”) Agonist Prodrugs Useful in the Treatment of Cancer and Methods Thereof
Nammi Therapeutics, Inc.
0 cites - US116791412023Formulated And/or Co-formulated Liposome Compositions Containing Toll-like Receptor (“TLR”) Agonist Prodrugs Useful in the Treatment of Cancer and Methods Thereof
Nammi Therapeutics, Inc.
0 cites